Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States

被引:79
作者
Theuer, CP
Wagner, JL
Taylor, TH
Brewster, WR
Tran, D
McLaren, CE
Anton-Culver, H
机构
[1] Univ Calif Irvine, Dept Med, Div Epidemiol, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Dept Surg, Irvine, CA 92697 USA
[3] Long Beach Vet Adm Med Ctr, Long Beach, CA USA
[4] Univ Calif Irvine, Dept Obstet & Gynecol, Div Epidemiol, Irvine, CA 92697 USA
[5] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA 92697 USA
[6] Congress Budget Off, Washington, DC USA
关键词
D O I
10.1053/gast.2001.22535
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background&Aims: Colorectal cancer screening beginning at age 50 is recommended for all Americans considered at "average" risk for the development of colorectal cancer. Methods: We used 1988-1995 California Cancer Registry data to compare the cost-effectiveness of two 35-year colorectal cancer screening interventions among Asians, blacks, Latinos, and Whites. Results: Average annual age-specific colorectal cancer incidence rates were highest in blacks and lowest in Latinos. Screening beginning at age 50 was most cost-effective in blacks and least cost-effective in Latinos (measured as dollars spent per year of life saved), using annual fecal occult blood testing (FOBT) combined with flexible sigmoidoscopy every 5 years and using colonoscopy every 10 years. A 35-year screening program beginning in blacks at age 42, whites at age 44, or Asians at age 46 was more cost-effective than screening Latinos beginning at age 50, Conclusions: Colorectal cancer screening programs beginning at age 50, using either FOBT and flexible sigmoidoscopy or colonoscopy in each racial or ethnic group, are within the $40,000-$60,000 per year of life saved upper cost limit considered acceptable for preventive strategies. Screening is most cost-effective in blacks because of high age-specific colorectal cancer incidence rates.
引用
收藏
页码:848 / 856
页数:9
相关论文
共 45 条
[41]  
*WHO, 1990, ICD 0 INT CLASS DIS
[42]   Colorectal cancer screening: Clinical guidelines and rationale [J].
Winawer, SJ ;
Fletcher, RH ;
Miller, L ;
Godlee, F ;
Stolar, MH ;
Mulrow, CD ;
Woolf, SH ;
Glick, SN ;
Ganiats, TG ;
Bond, JH ;
Rosen, L ;
Zapka, JG ;
Olsen, SJ ;
Giardiello, FM ;
Sisk, JE ;
vanAntwerp, R ;
BrownDavis, C ;
Marciniak, DA ;
Mayer, RJ .
GASTROENTEROLOGY, 1997, 112 (02) :594-642
[43]   SCREENING FOR COLORECTAL-CANCER WITH FECAL OCCULT BLOOD TESTING AND SIGMOIDOSCOPY [J].
WINAWER, SJ ;
FLEHINGER, BJ ;
SCHOTTENFELD, D ;
MILLER, DG .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (16) :1311-1318
[44]   PREVENTION OF COLORECTAL-CANCER BY COLONOSCOPIC POLYPECTOMY [J].
WINAWER, SJ ;
ZAUBER, AG ;
HO, MN ;
OBRIEN, MJ ;
GOTTLIEB, LS ;
STERNBERG, SS ;
WAYE, JD ;
SCHAPIRO, M ;
BOND, JH ;
PANISH, JF ;
ACKROYD, F ;
SHIKE, M ;
KURTZ, RC ;
HORNSBYLEWIS, L ;
GERDES, H ;
STEWART, ET .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (27) :1977-1981
[45]  
1999, MMWR MORB MORTAL WKL, V48, P116